Advanced Accelerator Applications S.A. (AAAP) Earns Outperform Rating from JMP Securities
JMP Securities restated their outperform rating on shares of Advanced Accelerator Applications S.A. (NASDAQ:AAAP) in a report released on Monday morning. They currently have a $69.00 target price on the stock.
Several other equities analysts have also recently issued reports on the company. Jefferies Group LLC reissued a buy rating and set a $60.00 price target (up previously from $50.00) on shares of Advanced Accelerator Applications in a research report on Friday, September 1st. BidaskClub raised Advanced Accelerator Applications from a hold rating to a buy rating in a research report on Thursday, August 3rd. Zacks Investment Research downgraded Advanced Accelerator Applications from a buy rating to a hold rating in a research report on Tuesday, August 1st. Canaccord Genuity set a $47.00 price target on Advanced Accelerator Applications and gave the stock a buy rating in a research report on Thursday, July 27th. Finally, TheStreet downgraded Advanced Accelerator Applications from a c- rating to a d rating in a research report on Wednesday, June 14th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Advanced Accelerator Applications has a consensus rating of Buy and an average price target of $54.00.
Advanced Accelerator Applications (AAAP) opened at 65.74 on Monday. The firm’s 50-day moving average is $54.06 and its 200-day moving average is $43.28. Advanced Accelerator Applications has a 12 month low of $23.50 and a 12 month high of $68.00.
Advanced Accelerator Applications (NASDAQ:AAAP) last posted its quarterly earnings results on Thursday, August 31st. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.01). The business had revenue of $40.14 million during the quarter, compared to analyst estimates of $36.74 million. Advanced Accelerator Applications had a negative net margin of 33.83% and a negative return on equity of 16.05%. On average, equities analysts anticipate that Advanced Accelerator Applications will post ($1.00) EPS for the current year.
ILLEGAL ACTIVITY WARNING: This news story was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/10/05/advanced-accelerator-applications-s-a-aaap-earns-outperform-rating-from-jmp-securities.html.
A number of hedge funds have recently bought and sold shares of the business. OppenheimerFunds Inc. acquired a new position in shares of Advanced Accelerator Applications during the first quarter worth about $39,009,000. Artisan Partners Limited Partnership lifted its stake in shares of Advanced Accelerator Applications by 29.2% during the second quarter. Artisan Partners Limited Partnership now owns 547,338 shares of the company’s stock worth $21,368,000 after purchasing an additional 123,619 shares in the last quarter. PointState Capital LP acquired a new position in shares of Advanced Accelerator Applications during the second quarter worth about $5,247,000. Clearbridge Investments LLC acquired a new position in shares of Advanced Accelerator Applications during the first quarter worth about $3,471,000. Finally, Morgan Stanley lifted its stake in shares of Advanced Accelerator Applications by 2,208.1% during the first quarter. Morgan Stanley now owns 72,358 shares of the company’s stock worth $2,884,000 after purchasing an additional 69,223 shares in the last quarter. 37.51% of the stock is owned by hedge funds and other institutional investors.
Advanced Accelerator Applications Company Profile
Advanced Accelerator Applications SA is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer.
Receive News & Stock Ratings for Advanced Accelerator Applications S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Accelerator Applications S.A. and related stocks with our FREE daily email newsletter.